Enzo, Cancer Genetics Enter into Dye Labels Pact | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Enzo Biochem today said that it has entered into a supply and distribution deal with privately held Cancer Genetics (CGI) covering the use of Enzo Life Sciences' fluorescent dye labels for increasing signal intensity in labeling nucleic acids.

Under the non-exclusive agreement, Enzo Life Sciences will incorporate its labels into CGI's nucleic acid material that it and supplies to the research market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.